Therapeutic options for patients with hodgkin’s disease and non-hodgkin’s lymphoma who relapse after autologous transplant
✍ Scribed by Koen van Besien; Sonali Smith; Hillard M. Lazarus
- Book ID
- 107531914
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 284 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1527-2729
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The prognosis of relapsing Hodgkin's disease (HD) and high grade aggressive non‐Hodgkin's lymphoma (NHL) is generally poor since many of these patients fail to respond to second line chemotherapy. Radiation therapy has been reported as an effective but seldom used, alternative treatment
## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,